comprehensive -WSS

comprehensive

author：explore 2025-10-01 20:16:23 - browse：41694

Adobe

WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American companies, including in the biotech sector. Chinese biotechnology companies, the thinking goes, could threaten national security by giving the Chinese government access to the genetic and health information of Americans.

Just Wednesday, President Biden issued an executive order aimed at keeping sensitive data, including Americans’ genetic information, out of the hands of adversaries.

But American biotech companies worry they could become collateral damage if the government sloppily targets sanctions. They’re pushing back against legislation that would bar biotech companies from working with some Chinese companies, especially as the government takes aim at WuXi, a Chinese company considered a crucial partner for discovering, testing, and making medicines that has worked with such brands as Pfizer, AstraZeneca, and GSK.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

WSS

Congressmen charge Covid hearing ‘could have been an email’

Medicare to cover more brain scans for Alzheimer’s patients

Cognito secures funding to test medical device for Alzheimer's

Key House panel plots a new health care package

Commercial surrogacy can be ethical, despite pope’s claims

The lessons of Aduhelm, an Alzheimer's drug that was not to be

hotspot

comprehensive

hotspot

Heart attack and stroke risk calculators need revising

AI can’t replace a physician’s gut feeling

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biden tests positive for Covid

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Medicare to cover more brain scans for Alzheimer’s patients

Activists slam private health insurers over coverage restrictions

Key House panel plots a new health care package

Trump demands the U.S. pay no more for drugs than other countries … again

Cybersecurity threat forces Lurie Children's to take systems offline

Wikipedia

In early work, researchers turn to CRISPR to treat Alzheimer's

In early work, researchers turn to CRISPR to treat Alzheimer's

Do digital therapeutics have a future in medicine?

Juul spent big to court Black leaders to promote its e

SAMSHA loosens regulations on methadone treatment centers

Some dementia cases could be undiagnosed liver disease

focus

explore

hotspot

focus